Glenmark Pharmaceuticals Ltd
NSE:GLENMARK
Wall Street
Price Targets
GLENMARK Price Targets Summary
Glenmark Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for GLENMARK is 912.82 INR with a low forecast of 575.7 INR and a high forecast of 1 329.3 INR.
Operating Income
Forecast
Operating Income Estimate
Glenmark Pharmaceuticals Ltd
For the last 8 years the compound annual growth rate for Glenmark Pharmaceuticals Ltd's operating income is 2%. The projected CAGR for the next 3 years is 29%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GLENMARK's stock price target?
Price Target
912.82
INR
According to Wall Street analysts, the average 1-year price target for GLENMARK is 912.82 INR with a low forecast of 575.7 INR and a high forecast of 1 329.3 INR.
What is Glenmark Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
11%
For the last 8 years the compound annual growth rate for Glenmark Pharmaceuticals Ltd's revenue is 7%. The projected CAGR for the next 3 years is 11%.
What is Glenmark Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
29%
For the last 8 years the compound annual growth rate for Glenmark Pharmaceuticals Ltd's operating income is 2%. The projected CAGR for the next 3 years is 29%.
What is Glenmark Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
76%
For the last 8 years the compound annual growth rate for Glenmark Pharmaceuticals Ltd's net income is -6%. The projected CAGR for the next 3 years is 76%.
You don't have any saved screeners yet
